Engineering yeast to create protein pharmaceuticals
12 December, 2017Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells.
Tumour-suppressive protein patrols metastatis sites
12 December, 2017Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time.
Patient enrolment for CSL's biggest heart attack trial to begin in early 2018
06 December, 2017Australian-listed global bio-therapeutics company CSL has confirmed a Phase 3 clinical trial for CSL112, the company's novel therapy for reduction of early recurrent cardiovascular events in heart attack survivors.
Nearly 6% of cancers attributable to diabetes, high BMI
06 December, 2017UK researchers have revealed that diabetes and high body-mass index were the cause of 5.6% of new cancer cases worldwide in 2012 — equivalent to 792,600 cases.
LeafCann and WardMM partner for BPSD clinical trial
30 November, 2017LeafCann Research and Advisory has signed a clinical trial agreement with WardMM to sponsor and provide medicinal cannabis extracts for the latter's research and development program for the treatment of behavioural and psychological symptoms of dementia (BPSD).
Griffith Uni celebrates new biobanking resource, MoU with Gold Coast Health
28 November, 2017Griffith University is discussing a number of its recent initiatives as part the Gold Coast Health Research Week Conference.
New TGA rules assist access to medical cannabis
24 November, 2017The TGA has announced changes to its Special Access Scheme that will make it easier for medical practitioners to prescribe cannabis-based medicines for patients in need, under certain conditions.
Biomarkers — a silver bullet to cancer diagnosis and treatment, report
21 November, 2017Fast-tracking biomarker research has the potential to transform cancer diagnosis and treatment, according to a report by the University of South Australia's Sansom Institute.
Experts meet to discuss potential of particle therapy for cancer
13 November, 2017Medical and health experts from across Australia and New Zealand recently convened in Adelaide to discuss the way forward for particle therapy in Australia.
Zero Childhood Cancer program comes to WA
10 November, 2017The Zero Childhood Cancer program — said to be one of the world's most comprehensive child cancer personalised medicine studies — has finally reached Western Australia, seven weeks after its national launch.
Award-winning wearable sensor technologies could transform personalised medicine
06 November, 2017ANU has announced the winner of its inaugural Grand Challenge Scheme — a $50 million initiative to provide funding for transformative research with the potential to radically change our understanding of, and responses to, the world's most intractable problems.
Acid reflux drugs claimed to double stomach cancer risk
03 November, 2017The long-term use of proton pump inhibitors (PPIs), a class of drugs commonly used to treat acid reflux, has been linked by researchers to a highly increased risk in the development of stomach cancer.
Researchers map drug development trends
02 November, 2017G protein-coupled receptors (GPCR) are a target of around 40% drugs. A major mapping of these drugs by researchers has found that their pharmacological mechanisms are becoming more complex.
Why do Alzheimer's drugs work in the lab but not in patients?
31 October, 2017Japanese researchers have been investigating the reasons why so many trials of drugs for Alzheimer's disease fail, particularly after they have shown promise in the lab.
Aphria ships cannabis oil to Australia for pain management trial
24 October, 2017Canadian medical marijuana producer Aphria has completed its first shipment of cannabis oil to Australian medical life science company Medlab Clinical Limited.
